Who drowned in Bollywood 350 crores, his picture took 200 crores in 5 days
Rahul Tiwari April 01, 2025 06:21 PM

In the year 2024, Akshay Kumar and Tiger Shroff's film 'Bade Mian Chhoti Mian' came on the occasion of Eid. The film was prepared in a huge budget and the fans had high expectations from it, but the film flopped badly at the box office. In this film, a popular actor from South also worked who is now wreaking havoc at the box office through a recent release.

A film of this actor from South has been released recently. Along with acting in it, he has also directed it. Last year, his film 'Bade Mian Chhoti Mian' proved to be a disaster by releasing on Eid, while now one of his films has earned 200 crores within 5 days and has earned 200 crores within 5 days.

Prithviraj's L2: Empuran wreaked havoc

The actor and director Prithviraj Sukumaran is being talked about here. Prithviraj has directed the recently released Malayalam film L2 Emopuran. He is also playing the role of Zayed Masood Azhar in it. While the lead role is played by Malayalam superstar Mohanlal. Mohanlal's film earned around 65 crores from all over the world on Opening Day. Whereas within five days it has crossed the Rs 200 crore mark. L2: Empuran has also become the fastest Malayalam film to earn Rs 100 crore and Rs 200 crore.

View this post on Instagram

A post shared by aashirvad cinemas (@aashirvadcine)

Malayalam cinema's biggest opener became

L2 Emopuran knocked in theaters on 27 March. On the very first day, it collected $ 5 million (about 42 crore rupees) in overseas. While this film took an opening of 21 crores in India and it became the biggest opener film in the history of Malayalam cinema.

'Bade Mian Chhoti Mia' lost 250 crores

Prithviraj played the role of Eklavya in Akshay and Tiger's Badi Mian Chhoti Mian. The film was directed by Ali Abbas Zafar. Its budget was Rs 350 crore. But it earned around Rs 100 crore worldwide. The film fell at the box office and the makers had to suffer a loss of 250 crores.

© Copyright @2025 LIDEA. All Rights Reserved.